Taegtmeyer, A. B., J. Leuppi, and G. Kullak-Ublick. “Roflumilast – a Phosphodiesterase-4 Inhibitor Licensed for Add-on Therapy in Severe COPD”. Swiss Medical Weekly, vol. 142, no. 2930, July 2012, p. w13628, doi:10.4414/smw.2012.13628.